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Background: The discovery of cancer stem cells and tumor heterogeneity prompted the exploration of additional
mechanisms aside from genetic mutations for carcinogenesis and cancer progression. The aim of the present study
was to investigate the effect of cell fusion between mesenchymal stem cells and the gastric epithelial cells in
tumorigenesis.
Methods: Cell fusion between cord blood mesenchymal stem cells and human gastric epithelial cells was
performed in vitro. Cell scratch and transwell assays were performed to determine migration and invasion abilities
of the hybrids. The expressions of epithelial-mesenchymal transition-related proteins and genes were analyzed by
immunocytochemistry and real time quantitative PCR. Tumorigenesis of the hybrids was evaluated through in vivo
inoculation in nude mice.
Results: Hybrids expressed the phenotypes of both donor cells. Aneuploidy was observed in 84.1% of cells. The
hybrids showed increased proliferation, migration and invasion abilities compared with the parental cells. In
addition, the expression of N-cadherin and vimentin in the hybrids was significantly higher than that of the
epithelial cells, and the mRNA expression of the epithelial-mesenchymal transition-related genes, Twist and Slug, in
the hybrids was also increased compared with that of the parental epithelial cells. Furthermore, the hybrids formed
masses of epithelial origin with glandular structures in BALB/c nude mice.
Conclusions: These findings suggest that cell fusion between gastric epithelial cells and mesenchymal stem cells
may result in epithelial to mesenchymal transition and malignant transformation.
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Carcinogenesis and cancer progression are multiple step
processes that involve genetic mutation, cell-cell com-
munication, and cell micro-environment interactions.
Mutations are thought to be the principal pathway of
malignant transformation [1]. Normal cells can accumu-
late mutations that are necessary for stepwise malignant
transformation. However, the discovery of cancer stem
cells and tumor heterogeneity widens the question* Correspondence: humphreyhe@163.com
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unless otherwise stated.regarding possible mechanisms of carcinogenesis and
cancer progression. Cell fusion has been proposed as
one of the possible mechanisms of carcinogenesis [2,3].
Mutations that are insufficient to transform on their
own may combine through cell fusion to result in car-
cinogenic transformation. Some studies have shown that
the expression of oncogenes or a mutated tumor sup-
pressor p53 in one of the fusion partners is sufficient to
produce heterogeneous progeny and result in oncogenic
transformation [4].
Cell fusion between healthy differentiated cells is
usually cytostatic and fails to generate oncogenic cells
[5]. However, cell fusion produces a wide range ofis an Open Access article distributed under the terms of the Creative Commons
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chromosome disjunctions, and translocations [6]. The
potential pathological consequence of fusion between
bone marrow-derived stem cells (BMDSCs) and epithe-
lial cells remains to be unknown. We previously hypo-
thesized that fusion between an “altered” pre-malignant
cell and a bone marrow-derived stem cell results in ma-
lignant transformation of the hybrid progeny cells [2].
The “altered” cells are defined as any cells with genetic
or epigenetic changes sufficient to change the normal
differentiation pathway of BMDSCs after fusion. In this
study, we fused immortalized GES-1 cells with cord
matrix-derived mesenchymal stem cells (CM-MSCs).
GES-1 is a SV40-immortalized non-tumorigenic human
gastric epithelial cell line [7]. GES-1 cells carry the SV40
T antigen and are non-tumorigenic when inoculated into
nude mice. Mesenchymal stem cells (MSCs) are self-
renewing stem cells residing in different tissues that can
differentiate into multiple cell types, including osteo-
cytes, chondrocytes, adipocytes, hepatocytes, myocytes,
neurons and cardiomyocytes. The results revealed that
the hybrids of GES-1 and CM-MSCs undergo epithelial-
mesenchymal transition (EMT), indicated by the increased
capability of proliferation, migration and invasion, and the




Ethical and methodological aspects of the investigation pro-
tocols were approved by the Ethics Committee of Tianjin
Medical University (Permit Number: TMUaMEC2008010).
Cell lines
CM-MSCs were provided by Union Stem Cell & Gene
Engineering Co. Ltd (Tianjin, China) and maintained in
complete DMEM/F12 cell culture medium. GES-1, an
immortalized and non-tumorigenic human gastric epi-
thelial cell line established by Beijing Institute for Cancer
Research, was generously provided by Dr. Chunsheng
Kan from Tianjin Neurology Institute (Tianjin, China)
and maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum
(Invitrogen, Beijing, China), 2 mM glutamine, 1 mM pyru-
vate, 50 μM 2-mercaptoethanol, penicillin (200 units/ml),
and streptomycin (200 μg/ml) at 37°C in a 5% CO2
atmosphere.
CM-MSCs and GES-1 cell fusion
Before fusion, GES-1 cells and CM-MSCs were cultured
separately in complete DMEM/F-12 culture medium
containing 10% fetal bovine serum (FBS). 5, 6- carboxyflu-
orescein diacetate succinimidyl ester (CFDA-SE, 2 μL/mL)
was added to the culture medium of CM-MSCs for20 min, following which the cells were washed twice with
PBS and resuspended with culture medium. GES-1 cells
were stained with PHK-26 according to the manufacturer’s
protocol (Sigma-Aldrich, MO, USA). In brief, 2 × 107 cells
were collected and resuspended in 1 mL of diluent C, and
4 μL of PKH26 was mixed with 1 mL of diluent C. The
two solutions were mixed together and incubated at am-
bient temperature for 5 min. Then 2 mL of FBS was added
and incubated for 1 min, following which 4 mL of com-
plete culture medium was added and centrifuged at 400 × g
for 5 min. Cells were then transferred into another tube,
washed three times, and finally resuspended in suitable
medium. Polyethylene glycol (PEG) was used to induce
cell fusion. In brief, both GES-1 cells (2 × 106 cells) and
CM-MSCs (1 × 107 cells) were collected, washed with
phosphate-buffered saline (PBS) and resuspended with
10 mL of PBS. The cells were mixed together, centrifuged
at 400 × g for 5 min, and the supernatant was carefully re-
moved. Cells were resuspended in 1 mL of PEG and incu-
bated for 1 min. Then 20–30 mL of serum-free DMEM/
F-12 culture medium was slowly added to the tube and
the cells were carefully mixed. Cells were cultured at
ambient temperature for 2 min, incubated at 37°C for
10 min, and centrifuged at 150 × g for 10 min. The super-
natant was removed and the cells were resuspended in
serum-free culture medium. CFSE+PKH-26+ cells were
then sorted using FACS Aria (BD Biosciences, CA, USA).
The sorted cells were resorted to ensure a purity of GSE
+PKH-26+ cells >98%. Fused cells were then aliquoted into
a 96-well plate after serial dilutions. Cells were examined
at 12 h, and then every 24 h. Each well of the hybrids was
deemed as a different clone, and each clone was then sub-
cultured into a 24-well plate, a 6-well plate and then
25 cm2 flasks until they reached 90% confluency.
Hematoxylin and eosin (H&E) staining and cytokeratin-18
(CK-18) immunofluorescence (IF) of GES-1 and hybrids
Slides with deposited GES-1 or hybrids were fixed with
paraformaldehyde for 15 min at ambient temperature
and washed three times with PBS for 5 min each. For
H&E staining, standard protocols were applied after fix-
ation of cells. For CK-18 IF slides, hydrogen peroxide
(3%, v/v) was applied for 10 min after fixation of cells.
After washing, the slides were blocked with 1% bovine
serum albumin (BSA) solution for 20 min, and a mouse
primary antibody against CK-18 (Santa Cruz Biotechnology
CA, USA) was then applied, and slides were incubated
overnight at 4°C and then washed with PBS. Fluorescein
isothiocyanate (FITC)-conjugated anti-mouse IgG anti-
body of goat origin (Boster, China) was applied at room
temperature and the slides were incubated in dark for 1 h.
After washing, 20 μL of anti-fade mounting medium
containing 4′,6-diamidino-2-phenylindole (DAPI) was ap-
plied. Slides were then cover-slipped and observed using a
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lyzed using Image Pro Plus 6.0 (Media Cybernetics, MD)
software.
Flow cytometry analysis
CM-MSCs and hybrids were characterized by flow cy-
tometry after staining with the following antibodies:
CD45-FITC, CD34-FITC, CD105- Phycoerythrin (PE),
CD73-PE, CD90-PE, HLA-ABC-FITC, HLA-DR- FITC
(BioLegend, USA). In brief, 1 × 106 cells were collected
and washed twice with PBS, and resuspended in 50 μL
of PBS. Antibodies were then added and incubated for
30 min, washed twice with PBS, and cells were resus-
pended with PBS and analyzed with FACS Calibur (BD
Biosciences, USA).
DNA ploidy analysis of hybrids
DNA ploidy analysis was performed to analyze the hy-
brids. Cells were harvested, washed twice with PBS, and
fixed with 75% ethanol at 4°C overnight (>18 h). After
centrifugation at 1000 rpm at 4°C, ethanol was removed,
and cells were washed twice with cold PBS and in-
cubated in 200 μl of RNase A (1 mg/mL) at 37°C for
30 min, following which 800 μl of propidium iodide (PI)
was then added. The cells were mixed carefully, incu-
bated in darkness for 30 min and analyzed with FACS
Calibur flow cytometer (BD Biosciences, CA, USA).
Turtle blood cells at G0/G1 phase were used as a con-
trol, and cell cycle phase distribution, DNA index, and
percentage of cells in each phase were calculated using
Modifit software (Verity Software House, ME, USA).
Cell scratch test of hybrids
A scratch test was performed to assess the mobility of
the hybrids. In brief, cells were incubated in a 6-well
plate and at least five horizontal lines were drawn at the
back of the plate. Then, 5 × 105 cells were placed in each
well and cultured overnight. Straight scratches were then
made vertical to the line drawn on the back of the plate,
and the wells were washed three times with PBS to re-
move excess cells. Cells were cultured with serum-free
culture medium at 37°C with 5% CO2, and observed at
0 h, 24 h, 48 h, and 72 h.
Transwell assay of hybrids
Transwell migration and invasion assays were performed
to assess the migration and invasion of the hybrids, with
six wells used per cell type. In brief, Matrigel was not ap-
plied in the migration assay, but in the invasive assay
3.9 μg/μL Matrigel was added to coat the microporous
membrane (8 μm) in the upper compartment, and the
chamber was incubated at 37°C for 30 min to effect gel-
ation. Complete DMEM/F-12 culture medium with 10%
FBS was added into the lower compartment. GES-1,CM-MSCs, and hybrids cells were harvested, washed
and resuspended with serum-free culture medium. Then
1 × 105 cells were added into the upper compartment
and the cells were cultured at 37°C in 5% CO2. At the
time of observation, the upper chamber was carefully re-
moved from the well and its medium was removed. Re-
sidual cells were gently wiped from the upper chamber
and the well was stained with hematoxylin. The number
of cells that penetrated through the membrane was ob-
served and counted in five fields, including the center of
the membrane and four other random areas.
Tetrazolium dye (MTT) colorimetric cell proliferative assay
of hybrids
An MTT assay was performed to assess the proliferative
activity of the hybrids. In brief, GES-1 cells, CM-MSCs,
and the hybrids were harvested and aliquoted into a 96-
well plate at 4,000 cells per well. The assay was performed
at 24 h, 48 h, 72 h, and 96 h after culture. In brief, MTT
(5 mg/mL) was added into each well (20 μL/ well) and cul-
tured at 37°C for 4 h. The supernatant was carefully re-
moved, and DMSO (200 μL/ well) was added. The plate
was shaken for 15 min, and the absorbance (OD) was
measured at 570 nm. The proliferation curve was gene-
rated using the equation: OD of hybrids/OD of control
cells × 100%.
Immunocytochemistry staining
Cells cultured on coverslip were fixed and stained for
the expression of E-cadherin, N-cadherin and Vimentin.
The slides were stained with mouse anti-human anti-
bodies to E-cadherin (1:50), N-cadherin (1:50) and vimen-
tin (1:100) (Santa Cruz Biotechnology, CA, USA). After
washing, biotin-labeled goat anti-mouse IgG was added
and streptavidin enzyme complex and DAB were applied
(Boster, China). Cell positivity was multiplied by the inten-
sity of staining and the percentage of stained cells to form
a multiplicative score. The cases were sorted into four
subgroups: H score 0–1 referred to negative expression;
H score 2–3 to weak expression; H score 4–6 to moderate
expression; and H score 6–9 to strong expression.
Real-time quantitative PCR
Cells were homogenized and total RNA was isolated
using an RNeasy Mini kit (QIAGEN China Co, China)
following the manufacturer’s instructions. All samples
were treated with RNase-free DNase (QIAGEN China
Co, China). First-strand complementary DNA was made
from total RNA using the Quantscript RT Kit (Tiangen
Biotech, Beijing, China) according to the manufacturer’s
instructions. To quantify the expression levels of Twist
and Slug, real-time PCR amplifications were performed
with the Opticon2 real-time PCR system (MJ Research,
MA, USA). Real-time PCR assays were performed using
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in micro-reaction tubes. The PCR reaction was per-
formed in a final volume of 20 μL, consisting of 10 μL of
2× SYBR Supermix, 1.0 μL of each 5′- and 3′- primer
(10 pmol/μL), 3 μL of sample cDNA and 5.0 μL of ddH2O.
All samples were run in triplicate. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as an en-
dogenous RNA reference gene. Primers and product sizes
for Slug were upstream 5′-AACTACAGCGAACTGGA
CAC-3′, downstream 5′-AATGGAGCAGCGGTAGTC-3′,
143 bp. Primers and product sizes for Twist were up-
stream 5′-TTCTCGGTCTGGAGGATG-3′, downstream
5′-ACTGTCCATTTTCTCCTTCTC-3′, 129 bp. Primers
and product sizes for GAPDH were upstream 5′-GAA
GGTGAAGGTCGGAGTC-3′, downstream 5′-GAAGA
TGGTGATGGGATTTC-3′, 225 bp. The expression le-
vels for each target gene were calculated using the com-
parative threshold cycle (CT) method. The Δct values
were calculated according to the formula Δct = ct (gene of
interest)-ct (GAPDH) in correlation analysis, and the
2-ΔΔct was calculated according to the formula ΔΔct =Δct
(control group)-Δct (experimental group) for determi-
nation of relative expression. Data are represented as the
mean ± standard deviation (SD) from three independent
experiments.
Tumor formation rate in nude mice
GES-1, CM-MSCs, and the hybrids were collected and
1 × 107 cells were suspended in 100 μL of PBS. Cells
were then injected subcutaneously into the armpit area
of BALB/c nude mice (N = 8) and observed for 4 weeks
for tumor formation. Samples of the subcutaneous mass
were collected, and H&E staining and CK-18 IHC were
performed for pathologic analysis of the mass.
Statistical analysis
Statistical analysis was performed using SPSS 13.0 for
Windows (SPSS Inc., IL, USA). For proliferation and
transwell assays, values were expressed as means ± stan-
dard deviation (mean ± SD). Statistical significance bet-
ween different cells groups was evaluated by ANOVA,
followed by S-N-K’s post-hoc test. Fisher’s exact test was
performed to test the frequency difference of immu-
nocytochemistry staining (positive vs. negative) between
different cells groups. A p-value < 0.05 was considered sta-
tistically significant.
Results
Hybrids acquired phenotype of both partner cells
CM-MSCs were successfully cultured and collected. Ex-
pression of the most recognized surface antigen of CM-
MSCs, including HLA-ABC, SH2 (CD105) and SH4
(CD73), was analyzed by flow cytometry, with 99.69%,
99.74%, and 99.73% positivity, respectively. Expressionsof HLA-DR, CD45, and CD34 were also analyzed to as-
sess hematopoietic stem cell contamination; expressions
of these antigens were 0.01%, 1.59%, and 0.03% res-
pectively. After GES-1 (Figure 1A, B) and CM-MSCs
(Figure 1C, D) were labeled with PKH-26 and CFSE,
in vitro cell fusion between GES-1 and CM-MSCs was
performed.
CFSE+PKH-26+ cells were then sorted using FACS
Aria (BD Biosciences, CA, USA). The fusion efficiency
represented by double-positive cells was 5.77 ± 1.91%,
as determined by fluorescence-activated cell sorting
(FACS), and most of the cells expressed both PKH-26
and CFSE (Figure 1E–G) at day 1 after cell sorting. The
hybrids began growing colonies at day 5. H&E staining
showed that the morphologies of GES-1 cells (Figure 1I)
and hybrids (Figure 1J) were oval, spindle-shaped and
polygonal. Detection of CK-18 immunofluorescence in-
dicated high-level expression of CK-18 in the cytoplasm
of both GES-1 and the hybrids (Figure 1K–L). This ob-
servation indicates that the hybrids maintain the CK-18
characteristic of GES-1 cells. Both H&E and CK-18 IF
results detected an increase in the nuclear/cytoplasm ra-
tio in the hybrids (1.67 ± 0.24 for GES-1 vs. 0.83 ± 0.18
for GES-1, p < 0.05), which is a representative character-
istic of tumor cells. CD90, which is characteristically
expressed in CM-MSCs, was analyzed by FACS and
found to be expressed at a low level (2.68%) in GES-1
cells, 28.76% in the hybrids, and at 19.36% in CM-MSCs.
These results indicate that the hybrids acquired pheno-
types from both parental cells. Compare to GES-1 cells,
hybrids showed increased tumor-like characteristic.
Hybrids showed ploidy disorder and increased metastatic
and proliferation ability
DNA ploidy analysis was performed on the parental
and progeny cells. GES-1 and CM-MSCs were diploid.
The majority of hybrids were aneuploidy cells (84.10%)
(Figure 2A). The remainders were diploid (12.09%) and
polyploid (3.81%), a characteristic of tumor cells. In the
cell scratch assay (Figure 2B) the hybrids had greater
migration ability than GES-1. At 24 h, no significant dif-
ference was observed, but at 48 h the hybrids began to
migrate toward the center of the scratch. By 72 h, the hy-
brids filled the scratch, while GES-1 cells migrated toward
the center of the scratch but did not fill the area. CM-MSCs
filled the scratch at 48 h. Furthermore, in the transwell mi-
gration assay, GES-1 (31.57 ± 15.55 cells/field) (Figure 3A),
CM-MSCs (30.14 ± 18.75 cells/field) (Figure 3B), and hy-
brids (112.3 ± 10.36 cells/field) (Figure 3C) crossed the
microporous membrane at 24 h, but in the transwell inva-
sive assay only the hybrids cells (102.3 ± 24.33 cells/field)
(Figure 3D) were able to penetrate the Matrigel coating
and cross the microporous membrane. The numbers of
migrated cells are significant difference as comparing
Figure 1 GES-1 versus hybrids. GES-1 (A) and CM-MSCs (C) were stained using PKH26 (B) and CFSE (D) separately. At day 1 after in vivo cell
fusion and cell sorting, most cells expressed both PKH26 and CFSE (E–G), and the hybrids began growing colonies at day 5 (H). H&E staining
showed that the morphologies of GES-1 (I) and fusion cells (J) were oval, spindle or polygonal, and CK-18 IF results showed that CK-18 was
expressed in the cytoplasm in both GES-1 (K) and fusion cells (L). Magnification: 400×, Scale bar A-J = 25 μm; K-L = 20 μm.
He et al. BMC Cancer  (2015) 15:24 Page 5 of 11hybrids to GES-1 and CM-MSCs (Figure 3E). These re-
sults indicate that fusion of GES-1 with CM-MSCs not
only increase the migration ability, but also increase
the invasive ability of the hybrids. MTT results show that
the hybrids proliferate at a faster rate than GES-1 and
CM-MSCs (Figure 3F). No significant difference between
proliferation rates was observed on day 1 and 2, but the
proliferation rate of the hybrids significantly increased at
day 3 and day 4.Increased expression of EMT-related genes in hybrids
EMT is characterized by the loss of epithelial marker E-
cadherin and expression of mesenchymal markers includ-
ing N-cadherin and vimentin [8]. Immunocytochemistry
was performed to evaluate the expressions of E-cadherin,
N-cadherin and vimentin here. GES-1, CM-MSCs and hy-
brids were all negative for E-cadherin (Figure 4A, D, G).
GES-1 cells were weak for N-cadherin expression, CM-
MSCs were strongly positive, and the hybrids had
Figure 2 DNA ploidy analysis and cell scratch assays. (A) DNA ploidy analysis was performed on the parental and progeny cells. GES-1 and
CM-MSCs were diploid. The majority of hybrids were aneuploidy cells (84.10%) (Figure 2A). The remainders were diploid (12.09%) and polyploid
(3.81%). (B) Cell scratch results showed that hybrids had stronger migration ability than GES-1 cells. At 24 h, no significant difference was observed,
but at 48 h, hybrids migrated toward the center of the scratch and almost filled the area. By 72 h, hybrids migrated toward the center and filled the
area. CM-MSCs mirgrated fastest and filled the scratch at 48 h. Magnification: 100×, Scale bar 100 μm. Data are a representative of three experiments.
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pression, GES-1 was weakly positive, and both CM-MSCs
and the hybrids exhibited strong expression (Figure 4C,
F, I). Real-time PCR was performed to measure thetranscription of the EMT-related genes Twist and Slug in
GES-1, CM-MSCs and fusion cells. Compared with GES-1,
the mRNA expressions of Twist in CM-MSCs and fusion
cells were upregulated by (15.2 ± 8.7)- and (8.7 ± 2.1)-fold,
Figure 3 Migration, invasion and proliferation of GES-1, CM-MSCs, and hybrids. Transwell migration assay showed that GES-1 (panel A),
CM-MSCs (panel B), and hybrids (panel C) could pass through the microporous membrane at 24 h, but only hybrids (panel D) could penetrate
through Matrigel and cross the microporous membrane in the transwell invasion assay. Magnification: 100×, Scale bar 100 μm. Representative of
three experiments are shown. (panel E) Graph indicates the number of cells crossing the microporous membrane in the transwell (hybrids vs.
GES-1, p < 0.05; hybrids vs. CM-MSCs, p < 0.05), and number of hybrids penetrated Matrigel, indicated with hybrids(G). (panel F) Graph indicates
the proliferation curve of GES-1, CM-MSCs, and hybrids (hybrids vs. GES-1, p > 0.05; hybrids vs. CM-MSCs, p < 0.05). Means ± SD of representative
experiments are shown. A total of three experiments were performed.
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Slug in CM-MSCs and fusion cells were upregulated
by (27.8 ± 4.2)- and (9.2 ± 1.8)-fold, respectively (p < 0.05)
(Figure 4J).
Increased proliferation and tumorigenicity in hybrids
GES-1, CM-MSCs, and the hybrids were collected and
1 × 107 cells were injected subcutaneously into the arm-
pit area of BALB/c nude mice (N = 8) and mice were ob-
served for 4 weeks for tumor formation. At 7 days afterinjection, no mass was observed in those injected with
GES-1 (Figure 5A) or CM-MSCs (Figure 5B), However,
subcutaneous masses were observed in six of the eight
mice injected with hybrids cells 7 days after injection
(Figure 5C). With prolonged observation time, GES-1
and CM-MSCs group remained negative for subcutane-
ous masses , and the volume of four of the six masses
observed for hybrids group decreased (Figure 5D). H&E
staining (E) and CK-18 IHC (F) results showed that the
masses were of epithelial origin and gastric gland
Figure 4 Expression of EMT-related genes in hybrids. Cells grown on coverslips were fixed and stained for the expression of E-cadherin,
N-cadherin and vimentin. Magnification 200×. No E-cadherin expression was detected in all cells types (panel A, GES-1; panel D, CM-MSCs;
panel G, hybrids); N-cadherin expression was weak in GES-1 cells (panel B), while CM-MSCs had strong expression (panel E). The hybrids had
moderate N-cadherin expression (panel H). GES-1 cells expressed vimentin weakly (panel C), while both CM-MSCs (panel F) and hybrids
(panel I) had strong expression. Twist and Slug mRNA transcription were analyzed by quantitative RT-PCR. Compared with GES-1 cells, the mRNA
expressions of Twist in CM-MSCs and fusion cells were upregulated by (15.2 ± 8.7)- and (8.7 ± 2.1)-fold, respectively; similarly, the mRNA expressions
of Slug in CM-MSCs and fusion cells were upregulated by (27.8 ± 4.2)- and (9.2 ± 1.8)-fold, respectively (p < 0.05) (panel J). Means ± SD of three
representative results are shown.
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malignant tumor was found. This result indicated that
the tumorigenicity potential of normal epithelial cellsincreased after fusion with MSCs, which suggests
that cell fusion could participate in gastric cancer
carcinogenesis.
Figure 5 Subcutaneous injection of the hybrids. At 7 days after subcutaneous injection in BALB/c nude mice, no mass was observed in those
injected with GES-1 (panel A) or CM-MSCs (panel B), but masses were observed in mice injected with hybrids (panel C). With prolonged observation
time, GES-1 and CM-MSCs remained negative for subcutaneous masses, while the size of the masses decreased in mice injected with hybrids
(panel D). H&E staining (panel E) and CK-18 IHC (panel F) results show that the masses were of epithelial origin and gastric gland structures were
observed, but not show characteristics of malignant tumor. Magnification: 40×, Scale bar 200 μm. Data are representative of three experiments.
He et al. BMC Cancer  (2015) 15:24 Page 9 of 11Discussion
Mutations are believed to be the principal mechanism of
malignant transformation [9]. However, the discovery of
cancer stem cells and tumor heterogeneity suggests that
as the main characteristic of malignant tumors, the abil-
ity of invasion and metastasis is not determined solely
by genetic alterations. Recent evidence indicates that al-
ternative mechanisms, such as cell-cell fusion, may also
render cells with the ability to escape cell cycle control,
tissue invasion, and metastasis [10]. Herein, we report
that fusion between immortalized non-tumorigenic hu-
man gastric epithelial cells with CM-MSCs can produce
transformed hybrids and induce epithelial-to-mesenchymal
transition.
Cell fusion of normal mammalian somatic cells is a
tightly controlled process that is restricted to a few cell
types, and results in terminally differentiated mul-
tinuclear cells. However, cell fusion causes chromosomal
aberrations, which can have potential pathological con-
sequences. Cancer stem cells have been discovered in
solid tumors and are believed to initiate and sustain neo-
plastic growth; however, the origin of these cells remains
to be debated [11,12]. Normal stem cells with inherent
self-renewal capacity may acquire mutations and become
transformed. The rareness of tissue stem cells may coun-
ter this theory because of the low probability that they
could be targeted by mutations. Differentiated tissue
cells, especially epithelial cells in gut, undergo rapidturnover and rarely accumulate enough mutations to
become transformed. He et al. proposed a stem cell fu-
sion model where abnormal or pre-malignant somatic
cells, including benign tumor cells, fuse with BMDSCs
(including MSCs) to form malignant hybrids that can
promote carcinogenesis [2]. Conceptually, cell fusion be-
tween stem cells and mutated differentiated cells might
lead to the acquisition of self-renewal capacity that al-
lows further accumulation of transforming mutations. In
the present study, we used hybrids established from
in vitro cell fusion between GES-1 and CM-MSCs to in-
vestigate whether cell fusion results in carcinogenesis.
Hybrids acquired both CK-18 and CD90 phenotypes
from both parent cells, GES-1 and CB-MSC, and also
carried the characteristics of tumor cells, such as an in-
creased nuclear/cytoplasm ratio, increased proliferation
rate and aneuploidy. Migration and invasive ability of
the hybrids significantly increased in vitro and the hy-
brids were able to form subcutaneous mass of epithelial
origin in vivo. These results indicate that BMDSCs ac-
quire an epithelial phenotype through cell fusion, and
that cell fusion may be the mechanism for gastric epithe-
lial cells to acquire metastatic ability. In contrast to the
observation of Wang et al., which showed that fusion
between esophageal carcinoma cells and CM-MSCs sup-
pressed tumorigenicity [13], our results indicate that
tumorigenicity of the hybrids was superior to GES-1
cells, indicating that cell fusion may participate in gastric
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ferences in genetic background between the fusion part-
ners. In our study, the fusion partner for CM-MSCs was
immortalized non-tumorigenic GES-1 cells, whereas ma-
lignant tumor cells (EC9706 or KYSE150) were used by
Wang et. al. Further studies are needed to determine the
role of fusion between BMDCs and tissue cells in diffe-
rent disease conditions.
EMT is an evolutionarily conserved process that oc-
curs during development and may also be involved in
cancer. EMT generates cells with properties of stem cells
and contributes to tumor progression and metastasis
[14,15]. Previous studies have shown that breast cancer
stem cells display EMT characteristics and EMT plays a
major role in sustaining CSCs [16]. Several genes enco-
ding transcription factors, such as Twist, Snail and Slug,
have been shown to govern EMT in normal and trans-
formed epithelial cells [17]. During EMT, epithelial cells
lose apicobasal polarity and intercellular junctions pene-
trate into the extracellular matrix-rich compartment. E-
cadherin is a key component of adherens junctions and
the suppression of E-cadherin and a switch to the ex-
pression of mesenchymal cadherins, such as N-cadherin,
are characteristics of EMT that are associated with
tumor invasion [18]. In cancer, EMT is thought to be in-
duced by signals from the stroma associated with tu-
mors, such as hepatocyte growth factor, platelet-derived
growth factor, and transforming growth factor-beta
[19,20]. Herein, we show that fusion between epithelial
cells with MSCs cells may directly result in EMT of the
hybrids. Powell et al. reported that fusion between intes-
tinal epithelial cells with macrophages induce EMT,
which increased the migration and invasion ability both
in vitro and in vivo [21]. Therefore, cell fusion between
MSCs with mutated epithelial cells could link the origin
of cancer stem cells with EMT, and require further in-
vestigation. Furthermore, during tumor progression, cell
fusion between neoplastic cells with stroma MSCs may
be one of the driving forces of clone evolution and con-
tribute to tumor heterogeneity.Conclusions
The present study showed that fusion of gastric epithe-
lial cells with mesenchymal stem cells resulted in EMT
and malignant transformation. However, the proposal
that cell fusion can initiate malignant transformation
by no means excludes other mechanisms. We argue
that cell fusion between MSCs and epithelial cells may
be one of the mechanisms of EMT and malignant
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